Early Pregnancy Serum Concentration of Secreted Frizzled-Related Protein 4, Secreted Frizzled-Related Protein 5, and Chemerin in Obese Women Who Develop Gestational Diabetes Mellitus

نویسندگان

چکیده

Background: The aim of this study was to evaluate whether secreted frizzled-related protein 4 (sFRP4), 5 (sFRP5), and chemerin serum concentrations in early pregnancy are associated with the development gestational diabetes mellitus (GDM) an obese cohort. In previous studies, increased sFRP4 chemerin, decreased sFRP5 were GDM normal overweight women. Methods: exploratory case control study, sFRP4, sFRP5, determined by ELISA 50 women who developed 100 uncomplicated pregnancies. Serum samples obtained between 15+0–18+6 weeks’ age based on a priori known associations GDM, body mass index (BMI) maternal selected for adjustment multivariate analyses. Results: cohort (median BMI 35.7 kg/m2, IQR 33.2–40.3 kg/m2), biochemical markers showed no association GDM: odds ratio (OR) 0.44 (95% confidence interval (CI) 0.01–23.18, p = 0.687), OR 0.55 CI 0.09–3.52, 0.528), 3.47 0.05–227.72, 0.560). Adjustment did not influence association. None significantly correlated insulin resistance (HOMA2-IR). Conclusion: No found or concentration pregnant absence may indicate that these proteins play lesser biological role pathophysiology

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Inhibition of secreted frizzled-related protein 5 improves glucose metabolism.

Elucidating the role of secreted frizzled-related protein 5 (SFRP5) in metabolism and obesity has been complicated by contradictory findings when knockout mice were used to determine metabolic phenotypes. By overexpressing SFRP5 in obese, prediabetic mice we consistently observed elevated hyperglycemia and glucose intolerance, supporting SFRP5 as a negative regulator of glucose metabolism. Acco...

متن کامل

Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control for diabetes mellitus.

Diabetes mellitus is a life threatening disease and scientists are doing their best to find a cost effective and permanent treatment of this malady. The recent trend is to control the disease by target base inhibiting of enzymes or proteins. Secreted frizzled-related protein 4 (SFRP4) is found to cause five times more risk of diabetes when expressed above average levels. This study was therefor...

متن کامل

immunohistochemical analysis and role of secreted frizzled-related protein-4 in polycystic ovary-induced rat

objective: the role of wnt signaling and its antagonist; secreted frizzled related protein type 4 (sfpr4) was reported in rodent ovarian follicular development. this study examines immunolocalization of sfrp4 in ovaries of polycystic ovary (pco) rat model and evaluates its role in follicular growth arrest and its premature differentiation. materials and mathods: pco was induced with daily admin...

متن کامل

Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes.

A plethora of candidate genes have been identified for complex polygenic disorders, but the underlying disease mechanisms remain largely unknown. We explored the pathophysiology of type 2 diabetes (T2D) by analyzing global gene expression in human pancreatic islets. A group of coexpressed genes (module), enriched for interleukin-1-related genes, was associated with T2D and reduced insulin secre...

متن کامل

FrzA, a secreted frizzled related protein, induced angiogenic response.

BACKGROUND The secreted frizzled related proteins (sFRP) are soluble proteins thought to interfere with the Wnt signaling. Our group previously demonstrated that one of these members, sFRP-1/FrzA, is strongly expressed during early phases of the vascularization process in embryonic vasculature and in the endothelium of arteries and capillaries in adults and modulated vascular cell proliferation...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Diabetology

سال: 2022

ISSN: ['2673-4540']

DOI: https://doi.org/10.3390/diabetology3010016